Drugs / Interferon-a
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00178698 | Jul 2002 → Jun 2013 | gastric cancer, non-small cell lung carcinoma, small cell lung carcinoma | The University of Texas Health Science Center, Houston | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Interferon-a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00178698 ↗ |
| Known as | Interferon-alpha | “In addition, at the beginning of this treatment, you will begin low-dose Interferon-alpha that will continue for the entire duration of your participation in this study.” NCT00178698 ↗ |
| Route | Subcutaneous | “interferon-alpha 100,000 i.u. s.c.daily” NCT00178698 ↗ |